Search research articles
Contact Us
Filters
Showing results (181-190 of 189) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 189 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 14, 2021
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial
P Khaw, V Do, K Lim, et al.
Gynecologie, Obstetrique & Fertilite
|
August 30, 2002
[Standards, options and recommendations for the management of patients with invasive cancer of the cervix uterus (non-metastatic stage), abridged version]
M Resbeut, E Fondrinier, B Fervers, et al.
Gynecologie, Obstetrique & Fertilite
|
May 22, 2008
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]
D Querleu, P Bonnier, P Morice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2013
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG)
D Querleu, I Ray-Coquard, J M Classe, et al.
Neuro-Chirurgie
|
November 18, 2005
[Results of the Sainte-Anne - Lyons series of 318 oligodendroglioma in adults]
F Nataf, M Koziak, A-C Ricci, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 9, 2010
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]
R Remonnay, M Morelle, P Pommier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2017
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
S M de Boer, B G Wortman, T Bosse, et al.
Gynecologic Oncology
|
August 17, 2020
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
J Knoth, R Pötter, I M Jürgenliemk-Schulz, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 189) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 189 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 14, 2021
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial
P Khaw, V Do, K Lim, et al.
Gynecologie, Obstetrique & Fertilite
|
August 30, 2002
[Standards, options and recommendations for the management of patients with invasive cancer of the cervix uterus (non-metastatic stage), abridged version]
M Resbeut, E Fondrinier, B Fervers, et al.
Gynecologie, Obstetrique & Fertilite
|
May 22, 2008
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]
D Querleu, P Bonnier, P Morice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2013
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG)
D Querleu, I Ray-Coquard, J M Classe, et al.
Neuro-Chirurgie
|
November 18, 2005
[Results of the Sainte-Anne - Lyons series of 318 oligodendroglioma in adults]
F Nataf, M Koziak, A-C Ricci, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 9, 2010
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]
R Remonnay, M Morelle, P Pommier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2017
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
S M de Boer, B G Wortman, T Bosse, et al.
Gynecologic Oncology
|
August 17, 2020
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
J Knoth, R Pötter, I M Jürgenliemk-Schulz, et al.
Page
of 19